Roche Gets EU Approval for Breast Cancer Drug Perjeta

Roche said on Tuesday it clinched European approval for its breast cancer drug Perjeta, fueling the company’s hopes that the drug will become the standard of care for an aggressive, incurable form of the disease.
Yahoo! News